Mr. Tao joined JunHe LLP in 2001. He is a senior partner of JunHe capital market stream and head of life science practice, with focuses on PRC legal services relating to incubation, PE financing, mergers and acquisitions, equity incentive, domestic and overseas listings by various types of biotech and innovative device companies. Mr. Tao plays a leading role in a number of landmark IPO and listing deals involving STAR Market, ChiNext, HKEX, NYSE and NASDAQ and M&A deals involving China and overseas listed companies.
Tao Xudong
